Back to Agenda
Session 5: New Uses of External Controls Leveraging Patient Level Data and Statistical Matching or Weighting in a Regulatory Setting
Session Chair(s)
Ruthie Davi, PhD, MS
Vice President, Data Science and Statistician
Medidata, a Dassault Systèmes Company, United States
![Meiyu Shen, PhD](/_Images/member/Generic_Image_Missing-Profile.jpg)
Meiyu Shen, PhD
Expert Mathematical Statistician, Office of Translational Sciences, CDER
FDA, United States
Increased availability of patient-level data and recent regulatory decisions encouraging the use of innovative approaches to accelerate medical product development are fueling the impetus to incorporate external control data into clinical development settings. Potential patient-level data sources are wide-ranging and include historical clinical trials data available through growing data sharing programs, registry data collected in order to advance the understanding of a particular disease, and real-world data electronically stored as part of clinical practice. This session will 1) discuss statistical methods, such as matching and weighting, that are fueling the ability to create well-balanced external control cohorts, 2) examine statistical considerations specific to the various types of patient-level data sources, and 3) present case studies and examples of the use of external controls in clinical development and regulatory settings.
Learning Objective : At the conclusion of this session, participants should be able to:
- Describe the general approach for creating an external control from patient-level data
- Identify potential areas where these types of external controls may facilitate product development
- Discuss key factors affecting the adequacy of external controls for elucidating treatment effects
Speaker(s)
Speaker
Antara Majumdar, PhD
GlaxoSmithKline, United States
Director, Oncology Statistics
Across-Trial Propensity Score Analysis to Support Contribution of Components of Oncology
Brent McHenry, PhD
Bristol-Myers Squibb, United States
Director, RCC and Prostate Biostatistics Lead
Panelist
Aloka Chakravarty, PhD
Office of Data, Analytics, & Research, Office of the Commissioner, FDA, United States
Director, Data Analytics
Panelist
Pallavi Mishra-Kalyani, PhD, MS
FDA, United States
Deputy Division Director, DBV, OB, CDER
Have an account?